Exa-cel
VX21-CTX001-171
Phase 3 mab terminated
Quick answer
Exa-cel for Sickle Cell Disease is a Phase 3 program (mab) at VERTEX PHARMACEUTICALS INC / MA with 1 ClinicalTrials.gov record(s).
Program details
- Company
- VERTEX PHARMACEUTICALS INC / MA
- Indication
- Sickle Cell Disease
- Phase
- Phase 3
- Modality
- mab
- Status
- terminated